Sambucol Black Elderberry Supplements Break FDA Rules Complaint

February 25, 2021

With Covid-19 raging around the country, sales of “immune support” dietary supplements have been growing astronomically. Makers of products containing elderberry have benefitted. But the complaint for this class action alleges that PharmaCare US, Inc. violates the law, both because of the claims made for its elderberry products and because its elderberry extract “does not meet the definition of a dietary ingredient” under the Food, Drug, and Cosmetic Act (FDCA).

Case Event File: Sambucol Black Elderberry Supplements Break FDA Rules Complaint

Related to: Sambucol Black Elderberry Supplements Break FDA Rules Class Action